Unknown

Dataset Information

0

Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation.


ABSTRACT: Post-hoc subgroup analysis of the negative trial of interleukin-1? receptor antagonist (IL1RA) for septic shock suggested that patients with features of macrophage activation syndrome (MAS) experienced a 50% relative risk reduction for mortality with treatment. Here we seek a genetic basis for this differential response. From 1341 patients enrolled in the ProCESS trial of early goal directed therapy for septic shock, we selected 6 patients with MAS features and the highest ferritin, for whole exome sequencing (mean 24,030.7??g/ml, ±SEM 7,411.1). In total 11 rare (minor allele frequency <5%) pathogenic or likely pathogenic variants causal for the monogenic disorders of Familial Hemophagocytic Lymphohistiocytosis, atypical Hemolytic Uremic Syndrome, Familial Mediterranean Fever, and Cryopyrin-associated Periodic Fever were identified. In these conditions, seven of the identified variants are currently targeted with IL1RA and four with anti-C5 antibody. Gene-targeted precision medicine may benefit this subgroup of patients with septic shock and pathogenic immune variation.

SUBMITTER: Kernan KF 

PROVIDER: S-EPMC6320733 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation.

Kernan Kate F KF   Ghaloul-Gonzalez Lina L   Shakoory Bita B   Kellum John A JA   Angus Derek C DC   Carcillo Joseph A JA  

Genes and immunity 20180706 6


Post-hoc subgroup analysis of the negative trial of interleukin-1β receptor antagonist (IL1RA) for septic shock suggested that patients with features of macrophage activation syndrome (MAS) experienced a 50% relative risk reduction for mortality with treatment. Here we seek a genetic basis for this differential response. From 1341 patients enrolled in the ProCESS trial of early goal directed therapy for septic shock, we selected 6 patients with MAS features and the highest ferritin, for whole ex  ...[more]

Similar Datasets

| S-EPMC9505036 | biostudies-literature
2007-06-14 | GSE8121 | GEO
| S-EPMC8045732 | biostudies-literature
| S-EPMC5512699 | biostudies-literature
| S-EPMC8595268 | biostudies-literature
| S-EPMC3708901 | biostudies-literature
| S-EPMC10589548 | biostudies-literature
| S-EPMC8945007 | biostudies-literature
| S-EPMC5462395 | biostudies-literature